See also this year's filing and all EDGAR filings for this company.
PDF Report 0001373707_2016_Tetraphase_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001373707, Tetraphase Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 213,768,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 943,000 |
| 3 | remainder_Assets | 206,000 |
| 4 | LiabilitiesCurrent | 10,697,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 20,916,000 |
| 9 | ResearchAndDevelopmentExpense | 73,768,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 11,686,000 |
| 12 | remainder_NetIncome | -191,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 214,917,000 |
| 1 | Liabilities | 10,697,000 |
| 2 | Expenses | 94,684,000 |
| 3 | Revenues | 11,686,000 |
| 4 | StockholdersEquity | 204,220,000 |
| 5 | NetIncome | -83,189,000 |
| 6 | ComprehensiveNetIncome | -83,189,000 |
| 7 | BaseVar | 166,087,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.21 |
| 9 | EconomicCapitalRatio | 3.83 |
Edgar->Model Mapping
Feature Distribution
Change over Time
